X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Novartis with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ADCOCK INGRAM (S. Africa) - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   ADCOCK INGRAM
EQUITY SHARE DATA
    NOVARTIS
Mar-17
ADCOCK INGRAM
Jun-14
NOVARTIS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs855363-   
Low Rs666262-   
Sales per share (Unadj.) Rs219.0107.8-  
Earnings per share (Unadj.) Rs19.1-27.2-  
Cash flow per share (Unadj.) Rs20.3-22.5-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.084.6-  
Shares outstanding (eoy) m29.96168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.52.9 120.0%   
Avg P/E ratio x39.8-11.5 -346.7%  
P/CF ratio (eoy) x37.5-13.9 -270.3%  
Price / Book Value ratio x2.53.7 67.2%  
Dividend payout %52.40-   
Avg Mkt Cap Rs m22,77952,659 43.3%   
No. of employees `0000.74.3 15.7%   
Total wages/salary Rs m1,3933,305 42.1%   
Avg. sales/employee Rs Th9,736.24,239.5 229.7%   
Avg. wages/employee Rs Th2,066.8769.9 268.5%   
Avg. net profit/employee Rs Th849.0-1,068.3 -79.5%   
INCOME DATA
Net Sales Rs m6,56218,200 36.1%  
Other income Rs m702127 550.4%   
Total revenues Rs m7,26418,327 39.6%   
Gross profit Rs m259-3,154 -8.2%  
Depreciation Rs m36786 4.6%   
Interest Rs m7493 1.5%   
Profit before tax Rs m917-4,305 -21.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m345269 128.3%   
Profit after tax Rs m572-4,586 -12.5%  
Gross profit margin %3.9-17.3 -22.8%  
Effective tax rate %37.6-6.2 -602.1%   
Net profit margin %8.7-25.2 -34.6%  
BALANCE SHEET DATA
Current assets Rs m9,73113,330 73.0%   
Current liabilities Rs m1,8307,500 24.4%   
Net working cap to sales %120.432.0 375.9%  
Current ratio x5.31.8 299.1%  
Inventory Days Days49111 43.9%  
Debtors Days Days25124 20.3%  
Net fixed assets Rs m577,770 0.7%   
Share capital Rs m14185 166.5%   
"Free" reserves Rs m9,0560-   
Net worth Rs m9,19614,285 64.4%   
Long term debt Rs m05,020 0.0%   
Total assets Rs m11,49926,986 42.6%  
Interest coverage x128.4-7.7 -1,660.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 84.6%   
Return on assets %5.0-15.2 -33.2%  
Return on equity %6.2-32.1 -19.4%  
Return on capital %10.1-19.8 -50.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,6050-   
CASH FLOW
From Operations Rs m-3801,554 -24.4%  
From Investments Rs m4,208-477 -882.1%  
From Financial Activity Rs m-3,3184,556 -72.8%  
Net Cashflow Rs m5105,633 9.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5 Rs / ZAR

Compare NOVARTIS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: UNICHEM LAB  STRIDES SHASUN LTD  JUBILANT LIFE SCIENCES  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Sensex Opens Flat; Metal Stocks Down(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.9% while the Hang Seng is down 0.1%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jun 22, 2018 12:27 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - IPCA LABS COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS